Effects of steroid hormones on fibrinolytic system in cultured human endometrial cells.
In a primary human endometrial cell culture, the addition of progesterone resulted in an approximately 2-fold increase in the amount of tissue-type plasminogen activator (t-PA) released into the culture media, with the minimal effective dose being 10(-7) M. In contrast, progesterone significantly reduced the release of urokinase-type PA (u-PA). Endometrial cells are known to release a major PA inhibitor, PAI-1. Progesterone stimulated the release of PAI-1. These observed effects of progesterone seem to be mediated through the progestin receptor in that R5020, a specific ligand for progestin receptor, mimicked the effects of progesterone, and RU486, an antagonist of progesterone, completely eliminated the effects of progesterone. It is notable that estradiol, when added alone or in combination with progesterone, caused no discernible effect on the release of PAs and PAI-1. These results suggest that progesterone is a key hormone in regulating the PA/plasmin system in the human endometrium, thereby playing a pivotal role in implantation and ensuing embryonal development.
Miyauchi
A
A
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Japan.
Osuga
Y
Y
Taketani
Y
Y
D002478:Cells, Cultured / Q000187:drug effects; D004717:Endometrium / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D015735:Mifepristone / Q000494:pharmacology*; D017395:Plasminogen Activator Inhibitor 1 / Q000819:agonists / Q000378:metabolism*; D010960:Plasminogen Activators / Q000187:drug effects / Q000378:metabolism*; D011374:Progesterone / Q000494:pharmacology*; D011397:Promegestone / Q000494:pharmacology
D017395:Plasminogen Activator Inhibitor 1; D015735:Mifepristone; D011374:Progesterone; D004958:Estradiol; D011397:Promegestone; D010960:Plasminogen Activators